RankingsPricing
  1. JP-listed companies
  2. ReproCELL Incorporated
  3. Financials
  4. Marketable securities, non-current

ReproCELL Incorporated【JP:4978】

Market cap
¥15.1B
P/E ratio
-201.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 20254,404+218.65%
Mar 31, 20241,382+37.45%
Mar 31, 20231,005-60.42%
Mar 31, 20222,540+367.66%
Mar 31, 2021543+1.05%
Mar 31, 2020538-42.19%
Mar 31, 2019930+73.81%
Mar 31, 2018535+54.33%
Mar 31, 2017347+226.12%
Mar 31, 2016106+68.39%
Mar 31, 201563

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)